Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome - Wikidata - wikimedia - TriplyDB

Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome

Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome

http://www.wikidata.org/entity/Q24634697

about

Atypical hemolytic uremic syndrome Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype Different disparities of gender and race among the thrombotic thrombocytopenic purpura and hemolytic-uremic syndromes Pre-emptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndrome Overview of C3 Glomerulopathy Advances and challenges in the management of complement-mediated thrombotic microangiopathies Current Understanding of the Role of Complement in IgA Nephropathy Current treatment of atypical hemolytic uremic syndrome Atypical hemolytic-uremic syndrome: a case report and literature review Production of biologically active complement factor H in therapeutically useful quantities Comprehensive analysis of Copy Number Variation of genes at chromosome 1 and 10 loci associated with late age related macular degeneration Haemolytic uraemic syndrome.Complement factor H gene associations with end-stage kidney disease in African Americans.Genetics and complement in atypical HUS.aHUS caused by complement dysregulation: new therapies on the horizon.Eculizumab induces long-term remission in recurrent post-transplant HUS associated with C3 gene mutation.Disease-associated N-terminal complement factor H mutations perturb cofactor and decay-accelerating activities.Novel developments in thrombotic microangiopathies: is there a common link between hemolytic uremic syndrome and thrombotic thrombocytic purpura?Age-related penetrance of hereditary atypical hemolytic uremic syndrome.Common genetic variants in complement genes other than CFH, CD46 and the CFHRs are not associated with aHUS.Factor I autoantibodies in patients with atypical hemolytic uremic syndrome: disease-associated or an epiphenomenon?Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristics Renal transplantation under prophylactic eculizumab in atypical hemolytic uremic syndrome with CFH/CFHR1 hybrid protein.Thrombotic microangiopathy and associated renal disorders.Anti-glomerular basement membrane glomerulonephritis and thrombotic microangiopathy in first degree relatives: a case report.Factor H autoantibodies and deletion of Complement Factor H-Related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndrome Neonatal onset atypical hemolytic uremic syndrome successfully treated with eculizumab.STEC-HUS, atypical HUS and TTP are all diseases of complement activation.Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies.Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome.Multifaceted hemolytic uremic syndrome in pediatrics.Complement disorders and hemolytic uremic syndrome.Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.Comprehensive analysis of glomerular mRNA expression of pro- and antithrombotic genes in atypical haemolytic-uremic syndrome (aHUS).Two patients with history of STEC-HUS, posttransplant recurrence and complement gene mutations.Complement therapy in atypical haemolytic uraemic syndrome (aHUS).Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy Long-term remission of atypical HUS with anti-factor H antibodies after cyclophosphamide pulses.Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome.

P2860

Q21202864-3EE0C8AF-458F-45ED-B728-DD267A85BF02 Q24606843-D5A11B2B-8323-4878-84A2-3A6EF0A72C67 Q24613907-2CC77BA6-2520-4F38-9CBF-0A9231F70661 Q24616851-28085FE5-AB0F-4B53-8D87-85F75C6398EA Q24622189-19F81824-5EA3-430B-AF4E-8F7E32640351 Q26747262-F2CD02FC-4238-4B28-8724-0FBBF48D88FE Q26796453-DBD2BBC2-615C-4B4C-986E-D9E766F7C7A5 Q26852163-969E9190-12C9-49D2-A24C-7AFF543070E8 Q27003211-C27180AB-4D0E-4D69-A14A-BD572209D0FD Q27003863-86CA2175-72D1-43A1-9AD9-9A1962D4168E Q28300280-6303101B-F492-4F53-9D94-3E478D767A0F Q28730260-CFC3A002-A32C-4565-942E-F79B9D4D7FC0 Q30244707-9C7F486F-8821-4539-9A86-00BCF68A88D0 Q30384517-7BC2744D-E63F-4BBC-989E-2D92F4DA9291 Q33389945-5561FFC6-4024-4ABD-9CB2-D863A8E3E083 Q33390198-30069B4F-4C1C-4C90-BCDC-24CE2804DC21 Q33393107-80B20B13-56A9-4983-A7C6-C47C77D5A8A8 Q33393852-0E6EA35D-C33B-4AEA-A75E-4A6862F1011B Q33395774-EC219DA5-3277-458D-985C-2F69078EF6E2 Q33397115-BE132CA3-1B50-4AF9-A43A-6170ED7BADC0 Q33398635-3A6F62D4-3A9C-482E-8385-FBC4D52CB629 Q33399052-4A3EE2F8-1AAE-4554-AD64-D2E34EE3B240 Q33400211-33F02FCB-F5C6-4CAB-A2C8-FAE96FEA6346 Q33400705-DD3AA9A7-F00F-486F-B96C-F4FA0F3ABA48 Q33402372-F55FDBAA-0530-4FDB-83C5-44D3ACDB8378 Q33402542-86634958-885B-4856-BEC6-C73B951A0264 Q33402827-7E99AB6E-7B7D-4FC6-9DFE-15B3206C169F Q33403172-4538655E-9EA2-48C9-A570-77DF7E863D9E Q33403359-78D1D76D-829A-4F87-BEC2-2B4AEE0AE014 Q33403607-B17EB8FE-241D-491F-950D-D4C8A4A42340 Q33404847-064EAA6B-BA5C-41C6-94A9-59C8B9349EFB Q33405452-B8A73EF2-3325-441F-8FA3-68C60A90A330 Q33405802-146FF5AA-8B43-4BDE-90A1-8AB7949F1FA8 Q33406025-993FA1C2-76C1-43AE-B405-5A4B40DF97A2 Q33406356-94E8B580-8B5E-4986-B64E-5F7E4D4D85B9 Q33408171-3A66C105-09A6-4959-9546-184506927B91 Q33408733-C357393A-E915-48EE-8165-6277FA9317EC Q33408788-4F3BE97A-07A9-498F-BFE3-52C4D0AF11F0 Q33409198-03FEFDE2-8D34-4D6C-800B-3B51BCBE8095 Q33410276-6E9699FF-570B-4FD3-84B7-BECC7780E232

P2860

Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome

http://www.wikidata.org/entity/Q24634697

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Association of factor H autoan ...... ical hemolytic uremic syndrome

@ast

Association of factor H autoan ...... ical hemolytic uremic syndrome

@en

Association of factor H autoan ...... ical hemolytic uremic syndrome

@nl

type

label

Association of factor H autoan ...... ical hemolytic uremic syndrome

@ast

Association of factor H autoan ...... ical hemolytic uremic syndrome

@en

Association of factor H autoan ...... ical hemolytic uremic syndrome

@nl

prefLabel

Association of factor H autoan ...... ical hemolytic uremic syndrome

@ast

Association of factor H autoan ...... ical hemolytic uremic syndrome

@en

Association of factor H autoan ...... ical hemolytic uremic syndrome

@nl

P1433

Q24634697-05B7C178-C093-4954-8D36-05631EE6836E

P1476

Q24634697-1FBAA02B-8D17-4214-A172-D6611CEB0E97

P2093

Q24634697-1532CDF9-830D-43BD-86AB-EAD8DDF8975E

Q24634697-1A664F42-E34D-4C47-9279-B87B7D93F20B

Q24634697-2146C553-0FB9-4587-B9C2-D90072082A19

Q24634697-66DEBC0B-AD01-49B3-807C-9B2C9AF1AE42

Q24634697-77052DBC-14C2-409D-AA35-AF062E20AEA1

Q24634697-9FD1065A-F51E-458F-B35B-1661C0EBF7E8

Q24634697-B99E30C6-B851-40B0-8B8B-FBE21F7E5E93

Q24634697-DD416AD4-B692-45EB-8328-E90AC2D6E62B

Q24634697-E8DE9F5E-66E7-41AC-A5CE-930D643EA584

Q24634697-F6818B97-9E88-4A23-9532-E1B826DAB0CE

P2860

Q24634697-075EE4F9-6024-4668-B682-E829DE03306B

Q24634697-0D30668D-4938-4E29-A039-111F01A02D35

Q24634697-22263610-B98C-4321-80A5-6B3F9C38D2F6

Q24634697-2CE6CE94-885F-4656-842E-513AC3FC5CA5

Q24634697-31A5FC56-E604-4F6C-8EF6-6467262B209F

Q24634697-324D5CDC-BAE1-4772-882B-C5F2E3F0675D

Q24634697-3B4A940C-48B2-4504-9B06-7789AA6EC2D4

Q24634697-45A83446-234E-495F-932A-B6B18C1B0CA5

Q24634697-4FFCB25F-663F-49F9-AAD9-D131C0431EEB

Q24634697-50A35F9D-D00A-4EDE-B5D0-A1DC56DB1AB7

P304

Q24634697-3D193A61-6548-49EA-A703-5C3636D5B0CB

P31

Q24634697-70E93C5D-9FDD-4BB1-AAA6-A00EC7017C46

P3181

Q24634697-C9937D2F-8C30-4483-B0C7-0A150DD233DF

P356

Q24634697-CA125950-E7F6-4D59-9DE1-EA4AB3B24AA1

P407

Q24634697-52470A87-C3CD-4DE6-B8F8-8EA69E216D4F

P433

Q24634697-B3A1AFB7-1C3C-41F0-9A66-04CA80FC9176

P478

Q24634697-0D16B2C7-9086-4DDD-AE82-2378692F3375

P50

Q24634697-E021D0C8-76B9-4399-93F4-E6494E273FBB

Q24634697-EF9828A7-077D-437B-BBCE-B83AA78CDB2B

Q24634697-F36B1F90-392B-4032-9B74-FDDEC52B9C2C

P577

Q24634697-FC8F15CF-2E6A-4601-846C-534AEC414CB6

P5875

Q24634697-6BCE38A6-5CA3-4028-914C-6A778A88CDD5

P698

Q24634697-A1110AD3-5CCE-4684-A034-0C654E3C0EE9

P921

Q24634697-0E1901B6-9C22-44AD-9AD8-EC5114814601

Q24634697-55B95440-E4CD-4D22-848F-A53C71350AC7

Q24634697-B6F74CFB-3DC9-4D8D-BF10-44B6C2FDB64F

P932

Q24634697-F238F40F-427E-4D0C-899C-3D0A2071B5D9

P3181

P356

BLOOD-2009-05-221549

P1433

P1476

Association of factor H autoan ...... ical hemolytic uremic syndrome

@en

P2093

Christoph Q Schmidt

http://www.w3.org/2001/XMLSchema#string

Iain Moore

http://www.w3.org/2001/XMLSchema#string

Isabel Pappworth

http://www.w3.org/2001/XMLSchema#string

Lisa Strain

http://www.w3.org/2001/XMLSchema#string

Lucy V Holmes

http://www.w3.org/2001/XMLSchema#string

Lynn Morgan

http://www.w3.org/2001/XMLSchema#string

Paul N Barlow

http://www.w3.org/2001/XMLSchema#string

Roy Ward

http://www.w3.org/2001/XMLSchema#string

Scott J Staniforth

http://www.w3.org/2001/XMLSchema#string

Timothy H J Goodship

http://www.w3.org/2001/XMLSchema#string

P2860

Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome

Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification

Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications

Complement factor H: sequence analysis of 221 kb of human genomic DNA containing the entire fH, fHR-1 and fHR-3 genes

A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration

A new map of glycosaminoglycan and C3b binding sites on factor H

Atypical haemolytic uraemic syndrome associated with a hybrid complement gene

The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome.

Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition

Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries

P304

379-87

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1798866

http://www.w3.org/2001/XMLSchema#string

P356

10.1182/BLOOD-2009-05-221549

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P50

Andrew P. Herbert

Kevin J Marchbank

P577

2010-01-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38040886

http://www.w3.org/2001/XMLSchema#string

P698

19861685

http://www.w3.org/2001/XMLSchema#string

P921

P932

2829859

http://www.w3.org/2001/XMLSchema#string